ARTICLE
Key Takeaways | The Morning After – Impact of the US Presidential Election on the Deal Environment
November 26, 2024
Read time: 5 min
During this session, the panelists discussed the potential for life sciences growth under the incoming Trump administration and the Republican-controlled-Congress, as well as opportunities for alignment in interests between the new administration and the industry to leverage innovative technologies. They also debated potential impediments to the life sciences sector, such as the Inflation Reduction Act of 2022 (IRA) and the BIOSECURE Act, and explored the impact of artificial intelligence (AI) and how it can be used to accelerate nationwide patient care gaps and improve current diagnostic technologies.
Session panelists:
- Kazi Helal, PhD, Senior Analyst, Emerging Technology, PitchBook
- Brian Johnson, President, MassMEDIC
- John Maraganore, PhD, Founding CEO, Alnylam Pharmaceuticals, Inc.; CEO and Principal, JMM Innovations, LLC
Top takeaways included:
- Advocacy and Alignment Will Play Pivotal Roles for the Life Sciences Industry Under the New Administration. The Trump administration will bring new agency, new health policy leaders, and new priorities (e.g., rural access and chronic conditions). However, strong science fundamentals could continue to play an important role under the new administration. Analogously, statewide leadership changes within life sciences agencies will impact the market on a regional scale. Additionally, the industry may see an increase in private equity life sciences deals while Big Pharma deals will continue to comprise a steady bulk of the venture capital market.
- The IRA’s Impact Remains Uncertain. It is unclear what policies the Trump administration will repeal or significantly change these next four years. The Biden administration’s policies, however, may survive through rebranding or modification. To date, the US Department of Health and Human Services has pushed to move drug negotiation policies forward but will face new opposition and ongoing legal challenges.
- The BIOSECURE Act May Disincentivize US Companies From Using Global Manufacturers for Drug Product Manufacturing. If Congress passes the BIOSECURE Act during its lame duck session, the US government could offer federal funding to life sciences companies that do not contract with “at-risk” biotechnology providers connected to certain foreign countries.
- A Potential Lack in AI Regulation. The United States is experiencing a rapid exodus of medical personnel from hospitals nationwide following COVID-19. In a rectifying attempt to stabilize operational costs and patient care, hospitals can look to deploy AI technologies. Newer AI technologies are being developed to triage patients in hospital emergency rooms and decrease wait times while more readily rendering lifesaving care. Despite the unclear (and seemingly limitless) boundaries surrounding the use and potential of AI on a global scale, AI in life sciences is dependent on future deregulation with necessary oversight. In line with the US’s shift to the Trump administration, however, AI technology may remain in its largely unregulated position unless state and local legislations influence the need for federal regulation.

CFPB Finalizes Rule for Federal Oversight of Popular Digital Payment Apps
ARTICLE / CLIENT ALERT
CFPB Finalizes Rule for Federal Oversight of Popular Digital Payment Apps
December 2, 2024
Read time: 27 min
On Nov. 21, 2024, the Consumer Financial Protection Bureau (“CFPB”) issued a final rule (“Final Rule”) that establishes its supervisory authority over nonbank covered entities identified as larger participants in the general-use digital payment applications market.[1] Covered entities will be subject to supervision to ensure compliance with Federal consumer financial laws, such as the Consumer Financial Protection Act (“CFPA”) and its prohibitions against unfair, deceptive, or abusive acts or practices (“UDAAPs”), the privacy provisions of the Gramm-Leach-Bliley Act and Regulation P, and the Electronic Funds Transfer Act and Regulation E.[2] This Alert provides an overview of the Final Rule and highlights key differences between the Final Rule and the previously released Proposed Rule, issued on Nov. 7, 2023 (“Proposed Rule”).[3]
What Is the Final Rule?
The Final Rule signifies another step in the CFPB’s continuous efforts to strengthen oversight of large nonbank entities that provide consumer financial products, with a specific focus on the most widely-used digital payment application companies, such as Apple, PayPal and Google. Notably, the Final Rule targets nonbank companies processing over 50 million transactions annually for supervision.[4] It authorizes the CFPB to conduct proactive examinations of these large technology firms concerning their digital payment activities. As highlighted in the CFPB’s press release, this expanded oversight aims to ensure stronger consumer protections across the digital payments sector.[5] The Final Rule is effective 30 days after its publication in the Federal Register. As of the publication date of this Alert, it has not yet been published in the Federal Register.
What Is the Final Rule’s Impact?
Providers designated as “larger participants” under the Final Rule should review and enhance their compliance management systems (“CMS”), including all applicable written policies and procedures, to prepare for supervision and examination by the CFPB. This preparation should include readiness to demonstrate their CMS. Larger participants should also proactively review their products, services, and related terms and conditions for potential risks of UDAAPs. Additionally, providers should be aware that the CFPB may examine other financial products and services beyond those directly tied to general-use digital consumer payment applications, which trigger larger participant status under the Final Rule. Separately, all providers (including smaller providers competing in the space) should monitor any forthcoming developments highlighted in the CFPB’s Supervisory Highlights, which the CFPB uses to publicize problematic conduct it identifies in covered markets.
Some industry participants have questioned—and continue to question—the CFPB’s authority to issue the Final Rule, in part because the CFPB has not clearly demonstrated the specific risks or harms that digital payment applications pose to consumers.[6] However, the CFPB clarified that its rulemaking authority is not based on identifying consumer harm but rather on its broad statutory ability to define “a larger participant of a market for other consumer financial products or services”[7] as well as its interpretation of the “financial data processing” prong of a covered “financial product or service” under the CFPA.[8]
Who Does the Final Rule Apply to?
The Final Rule applies to nonbank entities that qualify as larger participants in the general-use digital payment applications market. These are defined as entities that provide funds transfer or payment wallet functionalities through digital payment applications for consumers to make payments for personal, household or family purposes. Importantly, the Final Rule excludes certain transactions and entities that were initially included in the Proposed Rule, reflecting feedback from stakeholders during the rulemaking process.
- Modifications and Key Exclusions
Exclusion of Digital Assets: One of the most significant changes in the Final Rule is the exclusion of digital assets, such as cryptocurrencies, like Bitcoin and stablecoins, from the scope of “consumer payment transactions.” This marks a notable shift from the Proposed Rule, which initially included digital asset transactions under the definition of funds transfer activities.
The Final Rule defines “consumer payment transactions” as payments made to other persons for personal, household, or family purposes. However, when determining whether a nonbank entity qualifies as a larger participant, only transactions denominated in US dollars are considered under the calculation of “annual covered consumer payment transaction volume.” Specifically, the Final Rule defines “annual covered consumer payment transaction volume” to mean “the sum of the number of consumer payment transactions denominated in US dollars that the nonbank covered person and its affiliated companies facilitated in the preceding calendar year by providing general-use digital consumer payment applications.”[9]
By excluding digital assets from this calculation, the CFPB has limited the scope of its expanded oversight to traditional payment transactions. In its commentary, the CFPB explained that it “intends to continue to gather data and information regarding the nature of [digital asset] transactions and the impact of digital asset transactions on consumers, and to take further action as appropriate.”[10] This exclusion reflects the CFPB’s measured approach to regulating digital assets, acknowledging their unique characteristics and evolving role in the consumer financial ecosystem. The decision leaves open the possibility of future regulatory action specifically tailored to digital asset products and services as more data becomes available. However, the likelihood of such action will be influenced by the incoming Trump administration’s approach to financial regulation, which is likely to promote a less burdensome regulatory environment for the cryptocurrency industry. Nonetheless, nonbank entities should remain vigilant as federal and state regulators continue to assess the consumer implications of digital assets.
Checkout Processes and Marketplaces: The Final Rule excludes merchants and marketplaces that conduct payment transactions solely for sales through their own platforms. These activities are treated as distinct from the market for general-use digital consumer payment applications, which is the focus of the Final Rule. This exclusion applies to transactions confined within a merchant’s or marketplace’s ecosystem and does not extend to those facilitating payments between unaffiliated third parties outside the marketplace’s ecosystem. Importantly, the CFPB clarifies in the Final Rule that the marketplace exclusion still applies even where a marketplace facilitates payments to unaffiliated third-party sellers or merchants operating on the marketplace’s platform.[11]
Compared to the Proposed Rule, which tied the exclusion to marketplaces operating prominently under their own name, the Final Rule broadens the scope by removing branding requirements. Specifically, “the Final Rule treats a merchant or marketplace conducting payment transactions for sales through its own platform as distinct from the activity included in the market defined in this rule.”[12] The CFPB explained that it dropped the branding qualification because it could create confusion regarding the scope of the exclusion.[13]
- Refinements to Key Terms
The Final Rule introduces important clarifications to several key terms, refining the scope of the CFPB’s oversight. These refinements address stakeholder feedback and provide greater clarity compared to the Proposed Rule.
“Market”: In its “market” definition, the Final Rule defines “providing a general-use digital consumer payment application” to mean “providing a covered payment functionality through a digital application for consumers’ general use in making consumer payment transaction(s).”[14] This definition emphasizes that the market consists of payment applications facilitating transactions between multiple unaffiliated parties. The focus on “general use” ensures that applications confined to a single merchant or affiliated entities are excluded.
“General Use”: The term “general use” in the Final Rule refers to payment functionality that enables consumers to transfer funds to multiple, unaffiliated persons.[15] However, the Final Rule excludes from this definition payment functionalities provided solely for accounts excluded under Regulation E, such as prepaid payroll cards, government benefits accounts or payments for specific debts. The Final Rule adopts this refined definition to clarify the types of payment functionalities that qualify as “general use” and those that do not. This change aligns the Final Rule with its intended scope of overseeing broader payment networks rather than activities confined to specific use cases.
The CFPB opted for this alternative definition, rather than the Proposed Rule’s “absence of significant limitations on the purpose” standard, because it is clearer, more administrable, and reduces uncertainty. The Final Rule also aligns more closely with similar concepts in Regulation E, which defines prepaid cards as having “general use” when redeemable at multiple, unaffiliated merchants for goods and services. While the Final Rule adopts this framework, it broadens the concept to include consumer payment applications that facilitate payments to entities beyond merchants, such as family, friends or sole proprietors, unless an exception applies. This refined definition clarifies the types of payment functionalities that qualify as “general use” and ensures the Final Rule targets broader payment networks rather than activities confined to specific use cases.
“Covered Payment Functionality”: The Final Rule, generally adopting the Proposed Rule’s definition, classifies “covered payment functionality” into two main categories: funds transfer functionality and payment wallet functionality.
“Funds transfer functionality” is defined as the receipt of funds for the purpose of transmitting them or accepting and transmitting payment instructions (commonly referred to as peer-to-peer or P2P transfers) and clarifies that funds transfer functionality involves funds received or instructions accepted from market activities.[16] The Final Rule clarifies that funds transfer functionality applies to market activities where funds or instructions are received directly from a consumer.
“Payment wallet functionality” is defined as a product or service that stores account or payment credentials and transmits, routes or processes these stored credentials to facilitate consumer payments.[17] The Final Rule refines this term from “wallet functionality” to “payment wallet functionality” to enhance precision and address concerns about whether the rule might inadvertently apply to digital wallets or portions of their features that store and transmit data not directly related to consumer payments.”[18] Additionally, this term is further clarified to specify that account or payment credentials must be stored “for a consumer.” This clarification ensures the definition applies only to consumer-focused payment activities, excluding functionalities tied to business purposes or non-payment-related data storage, such as loyalty points or other non-monetary credentials. By narrowing the scope, the Final Rule aligns “payment wallet functionality” with its intended focus on consumer payment applications.
“Consumer Payment Transaction”: The Final Rule defines a “consumer payment transaction” as “the transfer of funds by or on behalf of a consumer who resides in a State to another person primarily for personal, family or household purposes.”[19] It expressly excludes: (i) international money transfers; (ii) funds transfers either linked to (a) the consumer’s receipt of a different form of funds, such as a currency exchange transaction, or (b) securities and commodities transfers;[20] (iii) payment transactions for the sale or lease of goods or services that a consumer selects from an online or physical store or marketplace; (iv) extensions of consumer credit made using a digital application provided by a person (or its affiliated companies) who is extending, brokering, acquiring or purchasing the credit; and (v) payments conducted by individuals for donations to fundraisers selected from a person’s (or its affiliated company’s) platform.[21]
One key refinement in the Final Rule is the shift from focusing on the consumer’s location at the time of the transaction to instead determining whether the consumer is a US resident. This change addresses feedback received during the rulemaking process that assessing a consumer’s physical location at the time of payment—especially for mobile transactions—would be impractical and burdensome for payment application providers. By focusing on residency, the CFPB aligns the Final Rule’s requirements with operational realities for covered entities.
What Is the Test?
The Final Rule establishes a two-pronged test, set forth below, to determine whether a nonbank entity qualifies as a larger participant in the market for general-use digital consumer payment applications, subjecting it to CFPB supervision. This test refines the framework originally proposed, incorporating feedback to better align with market realities. Entities meeting both criteria remain designated as larger participants for up to two years, even if their transaction volume subsequently falls below the threshold.
- Annual Consumer Payment Transaction Volume: To qualify as a larger participant, a nonbank entity (together with its affiliated companies) must facilitate at least 50 million consumer payment transactions in a calendar year. This threshold represents a significant increase from the 5 million transaction threshold set forth in the Proposed Rule, reflecting the CFPB’s response to concerns that the initial threshold risked sweeping smaller entities into supervision unnecessarily. The CFPB explained that the higher threshold ensures that only entities with substantial market impact fall under supervision. The agency estimates that the 50 million threshold captures approximately 98% of all consumer payment transactions in the market, while excluding smaller entities with minimal risk to consumers.
- Business Size: The nonbank entity must not qualify as a small business concern under the US Small Business Administration size standards. This criterion ensures that the Final Rule targets entities with sufficient operational and financial capacity to warrant federal supervision.
How Will the Recent Election Impact the Final Rule?
The recent election of Donald Trump introduces uncertainty about the Final Rule’s future. Historically, Trump’s administration prioritized deregulation, particularly in financial services, and reduced the CFPB’s enforcement actions under his first-term leadership. A similar approach is anticipated, with the new administration likely deprioritizing the Final Rule’s enforcement or defending it in court. This aligns with broader expectations that Trump’s CFPB will focus on high-visibility issues, such as credit card fees or fraud, rather than on regulating large technology companies.
Legal challenges to the Final Rule are another key factor. Industry groups have already signaled their intention to litigate, arguing that the CFPB exceeded its statutory authority. The Supreme Court’s recent elimination of Chevron deference adds weight to these arguments, as courts may now scrutinize the agency’s authority more rigorously.
While the Final Rule is also subject to the Congressional Review Act, early indications suggest that its repeal is unlikely to be a legislative priority given the new Congress’s crowded agenda. Instead, the opposition to the Final Rule is expected to play out primarily through litigation. Meanwhile, a reduced federal role in enforcement may lead state regulators to step up their oversight of digital payment applications, creating potential compliance challenges for businesses operating across jurisdictions.
The interplay of these factors—shifting federal priorities, legal vulnerability and active state regulators—means that businesses should monitor developments closely and prepare for a potentially fragmented regulatory environment.
Schulte Roth & Zabel’s lawyers are available to assist you in addressing any questions you may have regarding these developments. Please contact the Schulte Roth & Zabel lawyer with whom you usually work, or any of the following attorneys:
Donald J. Mosher – New York (+1 212.756.2187)
Kara A. Kuchar – New York (+1 212.756.2734)
Betty Santangelo – New York (+1 212.756.2587)
Melissa G.R. Goldstein – Washington, DC (+1 202.729.7471)
Adam J. Barazani – New York (+1 212.756.2519)
Jessica Romano – New York (+1 212.756.2205)
Jesse Weissman – New York (+1 212.756.2460)
Julianna R. Pasquarello – New York (+1 212.756.2055)
Jonice Q. Jackson – Washington, DC (+1 202.729.7479)
[1] The Final Rule, including the CFPB’s commentary and Supplementary Information.
[2] Final Rule at 3.
[3] View the Proposed Rule: “CFPB Proposes New Federal Oversight of Big Tech Companies and Other Providers of Digital Wallets and Payment Apps.”
[4] Final Rule at 1.
[6] Final Rule at 52. The Supplementary Information to the Final Rule includes extensive discussion of potential risks of harm to consumers as well as public comments the CFPB received on these issues.
[7] See 12 U.S.C. § 5514(a)(1)(B), (a)(2).
[8] See 12 U.S.C. § 5481(15)(A)(vii) (“The term ‘financial product or service’ means … providing payments or other financial data processing products or services to a consumer by any technological means, including processing or storing financial or banking data for any payment instrument, or through any payments systems or network used for processing payments data, including payments made through an online banking system or mobile telecommunications network, except that a person shall not be deemed to be a covered person with respect to financial data processing solely because the person [is subject to one of two exceptions].”)
[9] Final Rule at 258.
[10] Final Rule at 106.
[11] Final Rule at 118 (“This change will make the larger-participant test more administrable by avoiding the need to evaluate the form or extent of name branding when evaluating which entities qualify for the exclusion.”).
[12] Final Rule at 108.
[13] Final Rule at 108, n. 225 (“Under the terms of the proposed exclusion, when a consumer selects goods or services from an online marketplace and the marketplace operator conducts the consumer payment transaction, that would have been excluded by paragraph (C) even if a third-party seller was involved in the sale.”).
[14] Final Rule at 256.
[15] Final Rule at 257.
[16] Final Rule at 139.
[17] Final Rule at 257.
[18] Final Rule at 139.
[19] Final Rule at 257.
[20] See 12 CFR § 1005.3(c)(4) (to be excluded, the security or commodity must be (i) regulated by the Securities and Exchange Commission or the Commodity Futures Trading Commission; (ii) purchased or sold through a broker-dealer regulated by the Securities and Exchange Commission or through a futures commission merchant regulated by the Commodity Futures Trading Commission; or (iii) held in book-entry form by a Federal Reserve Bank or Federal agency).
[21] Final Rule at 116-119.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. © 2024 Schulte Roth & Zabel LLP. All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

Post-Chevron Insights and Resources
ARTICLE
Post-Chevron Insights and Resources
December 2024
Read time: 4 min
On June 28, 2024, in Loper Bright Enterprises v. Raimondo, the US Supreme Court overruled the decades-old Chevron doctrine. This decision means that courts must now determine the meaning of federal statutes and effectively dismantles the authority that agencies held for more than 40 years to interpret statutory ambiguities. With this shift in the balance of power between agencies and courts, businesses are likely to face both increased risk and opportunity when interacting with agencies.
Explore our available insights and resources to stay up to date on doing business in a post-Chevron world. McDermott can help your company navigate the uncertainty and assess new opportunities, including through a regulatory litigation strategy.
Insights
Affirmative Litigation in the Post-Chevron Era: During Healthcare Litigation, Compliance and Investigations Forum 2024, a panel of legal counsel explored the implications of the Chevron deference’s end on Administrative Procedure Act litigation, extended timelines for challenging agency actions, and the overall impact on regulatory oversight.
How Three SCOTUS Decisions Could Impact Healthcare Organizations’ FCA and Agency CMP Litigation Strategies: Three Supreme Court decisions, including Loper Bright, will likely strengthen healthcare organizations’ ability to both affirmatively sue executive agencies to challenge regulations governing operations and defend enforcement actions.
Loper Bright and the 340B Statute: Loper Bright likely opened opportunities for further legal challenges to the Health Resources and Services Administration’s interpretation and application of the 340B statute, and we expect that much of the 340B statute will be subject to interpretation by federal courts.
Supreme Court Overrules Chevron, Opening Door for New Tax Reg Challenges: Taxpayer have new opportunities for taxpayers to challenge federal tax regulations, as courts will no longer defer to agency interpretations of ambiguous statutes. Challenges previously unsuccessful or not pursued may now have a greater chance of success.
Loper Bright Could Shift Outlook for FDA Challenges: Parties regulated by the US Food and Drug Administration (FDA) should pay attention to the important implications this decision has for the operation of the FDA and the prospects of legal challenges to FDA actions.
McDermottPlus Check-Up | June 28, 2024: The Supreme Court’s decision could fundamentally impact the federal rulemaking process, given that courts will have more discretion to reject agency expertise or interpretation.
Good News for SALT Taxpayers? Supreme Court Overturns Federal Agency Deference: While Loper Bright addressed deference to administrative agencies under the federal Administrative Procedure Act, its outcome may give state and local taxpayers a better chance of persuading state courts that a tax authority’s interpretation of a tax statute is invalid.
US Supreme Court Overturns Chevron Deference: The landmark decision in Loper Bright signals substantially enhanced opportunity for regulated entities to challenge agency rules and actions and to insist that agencies strictly comply with statutory mandates.
Webinars and Podcasts
2025 IP Outlook: Hot Topics for Patent, Trademark & Copyright Holders: Hear about the administrative interpretations affecting patent rights and enforcement strategies in the post-Chevron world.
New Frontiers for Regulatory Litigation Following Loper Bright: Material Opportunity for Health Systems: Learn why health systems may engage with regulatory litigation following the overturn of Chevron and the steps necessary for successfully doing so.
Doctrine Disrupted: Doing Business in a Post-Chevron World: View the key takeaways from and recording of a webinar that breaks down the Supreme Court’s decision and previews what lies ahead for the business community.
Supreme Court Overturns Chevron Deference: In light of the Supreme Court’s decision, we discuss what it means for the health industry.
Congress and the Chevron Deference: In anticipation of the Supreme Court’s decision, we discussed the implications it could have for Congress.
In the News
Immigration Proponents Get Boost From End to Chevron Doctrine, Bloomberg Law
SEC’s Ambitious Agenda Snagged as Supreme Court Limits Powers, Bloomberg Law
Chevron‘s End is Just the Start for Energized Agency Foes, Law360
In Chevron Case, Justices Trade One Unknown for Another, Law360
Post-Chevron: Lower Court Fights are Expected Over Ability to Challenge Pre-Loper Agency Rules, The National Law Journal
Supreme Court Pares Back Federal Regulatory Power, The Wall Street Journal

Navigating EU Sanctions: How Investment Funds and Corporates Can Meet the ‘Best Efforts’ Standard
ARTICLE / CLIENT ALERT
Navigating EU Sanctions: How Investment Funds and Corporates Can Meet the ‘Best Efforts’ Standard
November 29, 2024
Read time: 8 min
With the introduction of the 14th sanctions package, entities established in the European Union are required to ‘undertake their best efforts to ensure’ that non-EU subsidiaries they own or control do not undermine EU Regulation 833/2014 imposing EU sanctions against Russia, or EU Regulation 765/2006 imposing EU sanctions against Belarus. This obligation stretches to EU citizens, including those located outside the European Union, who control corporate and fund structures around the world.
The term ‘best efforts’ is not explicitly defined within the EU regulations. On November 22, 2024, the European Commission issued guidance on how to comply with this obligation in its Frequently Asked Questions on Russia sanctions (FAQ). The clarifications, however, largely reiterate obligations set out in the Preamble to the EU Regulation 2024/1745 which introduced the ‘best efforts’ requirement in June 2024.
In this alert, we summarize the key features of this provision, with a focus on how investment funds and other global corporates can meet the ‘best efforts’ standard. In response to the Commission’s overriding emphasis on awareness of one’s operations, existing structures and ongoing activities should be reviewed, and robust sanctions compliance policies should be put into place to efficiently navigate the increasingly turbulent EU sanctions landscape.*
Origins of the ‘Best Efforts’ Obligation
The roots of the ‘best efforts’ obligation lie in the lack of consensus among EU Member States on how to address Russia and Belarus sanctions circumvention. Initially, the proposed obligation was designed to hold EU companies fully responsible for any undermining of EU Russia and Belarus sanctions by their non-EU subsidiaries. However, this proposal has been watered down due to pressure from certain Member States arguing that the wording was too extensive and onerous.
The ‘best efforts’ requirement under the EU Russia and Belarus sanctions regimes applies to EU companies and EU nationals in respect of companies they own (i.e., in which hold 50% or more of the proprietary rights or have a majority interest) or control (i.e., they have the right to appoint or remove a majority of the board, the right to use assets of that company, or the right to manage it or exercise a dominant influence over it) outside the European Union.
Implementation Guidance
In its recently issued FAQ, the European Commission emphasizes the need for EU companies and their management to be aware of the activities conducted by the non-EU entities they own or control and the risks related to such activities.
While the determination on whether the business has actually exercised its ‘best efforts’ in ensuring that its non-EU subsidiaries comply with EU sanctions will depend on the nature, size and risk profile of the business, the Commission clarified that ‘best efforts’ may include:
- the implementation of internal compliance programs;
- systematic sharing of corporate compliance standards;
- sending internal newsletters and sanctions advisories;
- setting up mandatory reporting on sanctions breaches; and/or
- organising mandatory sanctions trainings.
According to the FAQ, any of the following may amount to a breach of this obligation:
- knowledge of activities undermining EU sanctions;
- failure to block transactions undermining EU sanctions; and/or
- failure to carry out appropriate due diligence regarding activities of non-EU subsidiaries which resulted in undermining EU sanctions.
In this respect, the German Central Bank also confirmed that this obligation should be seen as satisfied when coherent and consistent mechanisms are implemented by EU entities allowing them to ensure that non-EU subsidiaries adhere to the EU sanctions.
Additionally, as clarified in the FAQ, the only valid defence to failure to comply with the ‘best efforts’ obligation is if the EU company no longer controls the non-EU subsidiary due to external reasons such as, for example, nationalization or compulsory administration. The European Commission expressly stated that liability will not be mitigated in the event that control over the subsidiary is lost due to the EU entity’s own actions, for instance, due to its previous risk-prone decisions to operate in Russia or Belarus. Likewise, EU parent companies or their employees’ decisions to recuse themselves from any Russia and Belarus related business of their subsidiaries would undermine the ‘best efforts’ obligation.
Compliance with the ‘Best Efforts’ Obligation by EU Investment Funds
The European fund industry will be affected by the ‘best efforts’ obligation on multiple levels. All regulated EU investment vehicles such as collective investment undertakings (CIUs) managed by undertakings for collective investment in transferable securities (UCITS), or alternative investment funds (AIFs), managed by alternative investment fund managers (AIFMs) must comply with this requirement in respect of all non-EU entities that they own or control within their structures. Additionally, the obligation may apply to Limited Partners (LPs) who own the entities. The Ultimate Beneficial Owners (UBOs) of both LPs and fund managers, as relevant, who hold EU passports may also be held personally liable in case of breach.
As a result, EU funds and corporates, irrespective of geographic markets or the sectors they operate in, should carefully assess their roles and determine who exactly has the responsibility to ensure the compliance of non-EU entities with EU Russia and Belarus sanctions, and decide on how compliance can practically be assured within the specific corporate structure. As a follow-up, if any exposure to Russia or Belarus is identified, stand-alone group sanctions policies should be put in place in line with the ‘best efforts’ requirement. It is no longer sufficient for the fund to impose a general ban on activities or investments touching upon Russia or Belarus. The fund and the involved parties, including any EU holding companies and concerned UBOs who are EU nationals, are now required to actively ensure that all umbrella entities (owned or controlled by them) are not involved in any activities that would be prohibited under EU Russia and Belarus sanctions.
Identifying prohibited activities may not be an easy task. In addition to prohibitions on the export of numerous types of goods or services to Russia or Belarus from non-EU entities, certain imports from Russia or Belarus, including non-EU intragroup trade, may also be restricted. In relation to fund managers, prohibited activities could include, for instance, the purchase, sale, provision of investment services, or dealing with transferable securities and money-market instruments issued by Russian or Belarussian companies subject to EU sanctions. In practice, trading in securities issued by these companies may be restricted, regardless of whether the trading is made through a non-EU entity or occurs on non-EU primary or secondary markets. The same may apply to trading in units or shares of CIUs, regardless of their denomination, particularly if they provide exposure to securities issued by Russian or Belarussian entities.
In the FAQ, the Commission has followed teleological interpretation of the prohibitions and insists on primarily taking into account the goal of particular sanctions (e.g., to weaken Russia’s economic base and curtail its ability to wage war), instead of the literal wording of the underlying prohibition. It remains to be seen if this approach will be shared by EU national authorities and courts. As clarified by the European Commission, the mere fact that an EU company (or an EU citizen who controls it) is aware that a non-EU subsidiary is involved in activities undermining EU Russia or Belarus sanctions is sufficient to conclude that the EU company did not comply with its ‘best efforts’ obligation. Therefore, EU funds who fail understand Russia / Belarus sanctions related risks and put in place comprehensive sanctions policies extending to their non-EU subsidiaries could find themselves exposed to potential liability.
The penalties for sanctions violations are set out in EU Directive 2024/1226 on sanctions criminalization and include prison sentence of at least 5 years (in the case of natural persons) and a maximum fine of at least 5% of worldwide turnover (in the case of companies), although EU Member States may impose even higher penalties at their discretion. Alongside increasing enforcement risk from EU Member States which have begun focusing on non-EU activities, funds and corporates will be also faced with meticulous scrutiny by EU banks and financial institutions. In fact, it is market practice for EU lenders to require extensive warranties on absolute compliance with EU sanctions (including compliance with the ‘best efforts’ obligation) and for lenders to periodically request EU funds and corporates to explain how such compliance has been put in place.
US Exposure and Risk
EU investment funds should also monitor the activities of their US subsidiaries to the extent that there is any Russia or Belarus exposure. EU and US sanctions are not entirely aligned when it comes to restricted products or activities directed to Russia or Belarus, and this gap may widen if new trade policies are adopted by the US in the near future.
Currently, the United States does not have any blocking regulations that prevent its companies from complying with EU-imposed sanctions (such as EU Regulation 2271/96 which has countered certain US sanctions since its implementation in 1996), and we can only speculate on how the new US administration will respond to this situation. However, it is clear that any prudent EU fund operating globally would start preparing their sanctions policies now to enable quick and efficient navigation of potentially conflicting US and EU sanctions.
*Trainee Nicholas Hunt contributed to this article

CMS Releases CY 2026 Medicare Advantage and Part D Proposed Rule
ARTICLE / CLIENT ALERT
CMS Releases CY 2026 Medicare Advantage and Part D Proposed Rule
November 27, 2024
Read time: 7 min
On November 26, 2024, the US Centers for Medicare & Medicaid Services (CMS) released the Contract Year (CY) 2026 Policy and Technical Changes to the Medicare Advantage (MA) Program, Medicare Prescription Drug Benefit Program (Part D), Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (PACE) proposed rule (fact sheet; proposed rule). This is part of an annual rulemaking process that includes both substantive and technical changes to the MA, Part D, and PACE programs.
This year, the rule proposes new policies related to the coverage of anti-obesity medications in Part D and Medicaid, medical loss ratio and utilization management requirements, use of artificial intelligence (AI) tools, and more. Comments are due by January 27, 2025.
Coverage of Anti-Obesity Medication in Part D and Medicaid
CMS proposes to reinterpret the Social Security Act so that anti-obesity medications are no longer excluded from Part D or Medicaid coverage when used to reduce excess body weight and maintain weight reduction long-term for individuals with obesity. CMS would recognize obesity as a chronic disease, so coverage would be permitted even if an individual does not have other medically accepted indications for use of the drug, such as diabetes. CMS estimates that over 10 years, this proposed change would increase costs to the federal government by $24.8 billion for Part D and $14.8 billion for Medicaid. This is a proposal that may be scrutinized more closely by the incoming Trump administration before being finalized.
Medical Loss Ratio Rules
CMS has proposed several revisions to the medical loss ratio (MLR) regulations, many of which reflect similar changes recently implemented in the commercial and Medicaid MLR rules. For example, CMS proposes to require that provider incentive and bonus arrangements are tied to clinical or quality improvement standards to be included in the MA MLR numerator. CMS also proposes to require that administrative costs be excluded from quality-improving activities in the MA and Part D MLR numerators. Both changes are based on findings from CMS’s commercial market MLR audits, which led to changes in the commercial MLR regulations. Additionally, CMS is proposing new regulations governing MA and Part D MLR audits, including an appeals process, suggesting that we may observe an increase in government scrutiny and potential enforcement action related to MLR reporting in these markets.
Additional changes to the MLR rules relate to allocations of expenses between lines of business, the treatment of Medicare Prescription Payment Plan unsettled balances, new data requests from CMS regarding vertical integration and provider payment arrangements, and rules protecting that additional data from public release.
Building on Existing Prior Authorization and Utilization Mangement Safeguards
In the 2024 MA and Part D Rule, CMS codified enrollee protections related to prior authorization and utilization management to clarify when and how MA organizations (MAOs) can use these tools. The protections included, among other things, requiring MAOs to post internal coverage criteria publicly and requiring MAOs to establish a Utilization Management Committee to review all utilization management practices. These rules went into effect on January 1, 2024. CMS continued to address prior authorization processes throughout the year, including in the Interoperability and Prior Authorization Final Rule and through a set of frequently asked questions (FAQs).
CMS proposes to build on these safeguards by:
- Defining “internal coverage criteria” to mean any policies, measures, tools, or guidelines, whether developed by an MAO or a third party, that are not expressly stated in applicable statutes, regulations, national or local coverage determinations, or CMS manuals and are adopted or relied upon by an MAO for purposes of making a medical necessity determination
- Adding rules regarding the publication of internal coverage criteria on MAO websites
- Clarifying that decisions made contemporaneously with treatment are organization determinations and are, therefore, subject to appeal and other existing requirements
- Eliminating MAO discretion to reopen approved authorizations for hospital admissions.
Ensuring Use of AI Tools Does Not Permit Discrimination
In recent years, stakeholders have raised questions concerning the role of AI, algorithms, and similar tools in making coverage determinations. CMS described via FAQs that an algorithm or software tool can be used to assist MAOs in making coverage determinations, provided that such tools comply with all applicable coverage determination rules, and that algorithms and AI cannot be used to solely deny certain care. CMS published a request for information in January 2024 soliciting comments on MA plans’ use of AI and the potential impacts on health disparities.
CMS now proposes to revise the MA regulations to ensure that services are provided “[e]quitably irrespective of delivery method or origin, whether from human or automated systems[.]” When AI or automated systems are used, the systems must be used in a way that ensures equitable service access. CMS may conduct program audits and/or take enforcement action where an MAO fails to comply with the regulations.
Other Topics
- Regulating the Administration of Supplemental Benefits Through Debit Cards. MAOs often use debit cards to provide supplemental benefits. CMS proposes to clarify when and how debit cards may be used by an MAO and enrollee, add disclosure requirements around debit cards, and require MAOs to allow an enrollee to receive covered benefits through an alternative method if there is an issue in using the debit card. CMS is also proposing to clarify and codify existing guidance to prohibit MAOs from marketing the dollar value of a supplemental benefit or the method by which a supplemental benefit is administered. CMS is soliciting comments on all aspects of the proposal.
- Expanding CMS Review of Marketing Materials. CMS proposes to expand the definition of “marketing” to require submission and review of a broader universe of materials. CMS would require submission of all communication materials and activities that are intended to draw a beneficiary’s attention or influence a beneficiary’s plan enrollment decision. CMS seeks comments on the potential financial impact of the proposal. The proposal does not impact materials that are – and will continue to be – designated as “File & Use.”
- Adding Topics That Agents and Brokers Must Discuss With Prospective Beneficiaries. CMS has developed a list of topics that MAOs and Part D sponsors must ensure their agents and brokers discuss with beneficiaries prior to enrolling the beneficiary in a plan. CMS proposes to expand the number of required topics that must be discussed to include low-income subsidy eligibility, resources for state programs, and additional information for beneficiaries who are enrolling into an MA plan when first eligible for Medicare or those who are dropping a Medigap plan to enroll into an MA plan for the first time.
- Integrating Provider Directory Information Into Medicare Plan Finder. CMS seeks to enhance Medicare Plan Finder by making provider network information searchable for all MAOs. CMS proposes to require MAOs to submit provider directory information that is formatted to CMS’ specifications for use on Medicare Plan Finder, as well as attest to the accuracy of the data. Consistent with current provider directory standards, MAOs would be required to update the Medicare Plan Finder data within 30 days of receiving information from providers regarding a change in information. CMS proposes an applicability date of July 1, 2025, to allow for online testing and requests feedback on the attestation process.
A range of additional topics are addressed in the proposed rule.
Please reach out to your regular McDermott lawyers or Kate McDonald for more information on the proposed rule.

CPPA Opens Public Comment Period for Proposed CCPA Regulations
ARTICLE / CLIENT ALERT
CPPA Opens Public Comment Period for Proposed CCPA Regulations
November 26, 2024
Read time: 4 min
On November 22, 2024, the California Privacy Protection Agency (CPPA) opened the public comment period for the proposed California Consumer Privacy Act (CCPA) regulations related to cybersecurity audits, risk assessments, and automated decision-making technology (ADMT). The proposed regulations have been highly scrutinized over several months as a potential overreach by the CPPA, and the regulations were advanced to rulemaking over the objection of a CPPA board member. Since our July 2024 article, the regulations have been updated to fix grammatical issues, remove the section on consumer price index increases (which was addressed via legislation), and insert a description of the purported benefits of the new regulations. For a more in-depth look at the substance of the proposed regulations, see our earlier analysis.
Key Aspects of the Proposed Regulations
Cybersecurity Audits
Every business whose processing of consumers’ personal information presents “significant risk” to consumers’ security must engage an independent auditor to perform an annual cybersecurity audit and submit that audit to the CPPA. A business’s processing meets the significant risk to security threshold if it:
- Derives 50% or more of its revenue from selling or sharing personal information or
- Reaches the revenue threshold ($25 million) and
- Processes the personal information of 250,000 consumers or more in the previous calendar year or
- Processes the sensitive personal information of 50,000 or more consumers in the previous calendar year.
Privacy Risk Assessment
Under the proposed regulations, businesses must conduct and document a privacy risk assessment prior to any processing of consumers’ personal information that “presents significant risk to consumers’ privacy.” The proposed regulations require such assessments for a much broader set of processing activities than other states with consumer privacy laws, including selling or sharing personal information and processing sensitive personal information.
ADMT
If a business uses ADMT to make a significant decision or for profiling or training, it must provide a pre-use notice and honor opt-out and access rights. Significant decisions are decisions that result in access to, or denial of, certain critical social and cultural functions, including financial or lending services, housing, insurance, education enrollment or opportunities, employment or independent contracting opportunities or compensation, healthcare services, or essential goods or services. When businesses use ADMT for one of these purposes, it must conduct a privacy risk assessment that captures specific considerations related to ADMT, such as whether the ADMT works as intended for the proposed use and does not discriminate based on protected classes.
What Comes Next?
The public comment period will stay open until January 14, 2025, when the CPPA will hold a public hearing on the proposed regulations. After this period ends, the CPPA will consider the comments and may modify the proposed regulations. If the last rulemaking is any indication, we can expect modest but not major changes as a result of public comments, which would then trigger a second, shorter round of public comment.
Once the comment period(s) ends, the proposed regulations must be transmitted to the Office of Administrative Law for final approval before being filed with the Secretary of State. Given the numerous steps that must be taken before the proposed regulations can be finalized, the earliest the regulations could take effect would be April 2025.
If you are interested in commenting on the proposed regulations, we encourage you to contact your regular McDermott lawyer or one of the authors of this article.

#BakuBreakthrough? COP29 Sets a $300 Billion Goal as Part of a $1.3 Trillion Climate Finance Ambition
ARTICLE
#BakuBreakthrough? COP29 Sets a $300 Billion Goal as Part of a $1.3 Trillion Climate Finance Ambition
November 26, 2024
Read time: 8 min
As we have previously reported over the last two weeks, the 29th Annual United Nations (UN) Climate Change Conference (COP29) focused heavily on climate finance and implementing key strategies for global emissions reduction, particularly to limit a global warming to 1.5°C.
In this article, we share the key takeaways from COP29 for governments, multilateral institutions, investors, financial institutions, and other key stakeholders. While the world watches to see if the United States does withdraw from the Paris Agreement, work will continue to progress crucial outcomes agreed upon during COP29.
Overview
- Countries agreed to a “new commitment to channel $1.3 trillion of climate finance to the developing world each year by 2035,” which includes a core “target” commitment of $300 billion annually from developed countries.
- Governments agreed on standards for carbon markets under Article 6 of the Paris Agreement, which are aimed at streamlining carbon credit trading to accelerate emissions cuts.
- Set to mobilize aid starting in 2025, the Loss and Damage Fund (L&D Fund) was also advanced during COP29, marking significant progress in international climate cooperation – although final details are yet to be agreed upon.
The Baku Finance Goal
The Baku Finance Goal, also known as the New Collective Quantified Goal on Climate Finance (NCQG), sets a “target” for developed countries to mobilize at least $300 billion annually for developing countries by 2035. The annual funding goal prioritizes support for the least developed countries and small island developing states, with a focus on accessibility and transparency.
“This new finance goal is an insurance policy for humanity amid worsening climate impacts hitting every country,” said Simon Stiell, executive secretary of UN Climate Change. “But like any insurance policy, it only works if premiums are paid in full and on time. Promises must be kept to protect billions of lives.”
The $1.3 trillion finance goal “encourage[s] developing country parties to make contributions, including through South-South cooperation, on a voluntary basis.” This is partly because of ongoing questions surrounding the role of major emerging economies that were not considered developed when climate summits began in the 1990s, including China, India, Saudi Arabia, and other gulf states.
While parties are not mandated to provide grants, a clear theme throughout the text is the role of public finance and other sources mobilized by public finance. Parties are particularly called upon to significantly reduce the cost of capital by 2030 through the use of products such as first-loss instruments, guarantees, local currency financing, and foreign exchange risks, among other ways.
Article 6 of the Paris Agreement: Country-to-Country Trading and a Carbon Credit Mechanism Will Become Fully Operational
After a turbulent few years for carbon markets, governments have revived the prospects of a once nascent sector by approving rules that will create a global market for countries to meet their Paris Agreement commitments. Countries adopted operational standards for international carbon markets to enhance emissions reductions and finance flows to developing countries, which the UN will supervise.
Crucially, least developed countries will get capacity-building assistance if needed so they can enter the market in a meaningful and informed manner. Additionally, where relevant, projects will not be able to proceed “without explicit, informed agreement from Indigenous peoples.”
The new rules for a centralized carbon trading system, known as the Paris Agreement Crediting Mechanism, provide clarity on the creation, trading, and registering of emissions reductions and removals without double counting. This will allow heavy-emitting countries and businesses to purchase credits from decarbonization schemes in developing countries.
Involved parties approved essential guidelines for developing and evaluating carbon credit methodologies and carbon removal projects, which aim to operationalize Article 6.4 of the Paris Agreement by enabling countries to trade emissions reductions and removals while preventing double counting. The new rules also emphasize integrity and transparency, addressing past criticisms of carbon markets.
Initial credits under Article 6.4 will transition from Clean Development Mechanism projects, including renewable energy and efficiency initiatives. New methodologies for innovative carbon removal techniques were not agreed on (as predicted) but are expected by mid-2025, covering technologies like direct air capture and enhanced weathering.
The Article 6.4 Supervisory Body, which is made up of 12 members from the Paris Agreement parties, preemptively approved standards to break prior negotiation deadlocks. While this accelerated progress, it also drew criticism for bypassing national negotiators and limiting debate on the standards.
Despite the advancements, concerns were raised about procedural transparency and the risk of relying too heavily on carbon removal technologies. That said, further refinements to the Paris Agreement Crediting Mechanism are anticipated once it is implemented.
The Paris Agreement Crediting Mechanism is expected to save up to $250 billion annually in climate action costs by incentivizing developed countries to direct financing to developing nations in support of their sustainable development. It will also align voluntary and compliance carbon markets, potentially boosting demand for high-quality credits. This development represents a crucial step forward after years of delays and contentious negotiations.
Commitment to Operationalize the L&D Fund by 2025, Providing Financial Support for Climate-Impacted Nations
The L&D Fund, which has been discussed during many previous COPs, was established to support the most vulnerable countries in managing climate-related damage, such as damage from extreme weather events and rising sea levels. It also aims to provide financial assistance for recovery and rebuilding efforts in nations disproportionately affected by climate-related disasters.
The L&D Fund’s current commitments total more than $730 million, with major pledges from France, Italy, Germany, and the United Arab Emirates. However, additional pledges are still being sought to meet its goals, which some have costed at around $580 billion by 2030. Developed countries are expected to raise funding through taxes on fossil fuel profits and international flights, among other sources.
Discussions during COP29 highlighted an urgent need to streamline accessibility for affected countries and communities. Delegates from the Global South emphasized the immediate disbursement of funds and tailored approaches for regional and local needs. Additionally, there was significant focus on involving Indigenous peoples and local communities, ensuring direct support rather than intermediaries and leveraging their knowledge in sustainable climate adaptation strategies.
While a gap between pledged amounts and the amount required remains, now that there are additional operational details, including funding sources and governance, the L&D Fund should be fully functional and financing projects by 2025.
Other Developments Outside of the Headline Issues
- More than 75 governments and 1,100 members of the digital tech community endorsed the COP29 Declaration on Green Digital Action to use digital tools to reduce emissions and strengthen climate resilience.
- The Colombian government’s call for a global treaty on energy transition minerals was backed by several countries at COP29. Such a treaty would set global standards for the governance of mineral supply chains (particularly for cobalt, lithium, and nickel), look to increase economic opportunities for countries and people at the beginning of the chain, and establish “no-go zones” to protect nature.
- Countries were urged to commit to an energy storage target of 1.5 terawatts by 2030, which would enable the much talked about tripling of world renewable energy capacity.
- Six new countries – El Salvador, Kazakhstan, Kenya, Kosovo, Nigeria, and Turkey – joined the COP28 pledge to triple global nuclear capacity by 2050, bringing the total number to 31 countries.
- Multilateral development banks, such as World Bank, announced that their climate finance contributions are projected to reach $170 billion annually by 2030, with $120 billion being targeted toward low- and middle-income countries.
- Various development finance institutions signed a pledge to support green hydrogen projects in emerging and developing economies.
- Mexico announced its commitment to net-zero emissions by 2050, which means all G20 members have now committed to a net-zero target.
Potential US Withdrawal From the Paris Agreement
As expected, the elephant in the room during COP29 was the US’ potential withdrawal from the Paris Agreement.
US Climate Envoy John Podesta and White House Climate Adviser Ali Zaidi made it clear that efforts to mitigate the effects of climate change will likely remain a priority at the state level at the very least.
Not only has the US, China, and Azerbaijan convened a summit to accelerate actions to cut methane and other non-CO2 greenhouse gases, but the US Environmental Protection Agency announced a final rule to reduce methane emissions from the oil and gas sector. The rule facilitates the implementation of US Congress’ directive in the Inflation Reduction Act of 2022 to collect a Waste Emissions Charge to better ensure valuable natural gas reaches the market rather than polluting the air.
“The fight is bigger than one election, one political cycle in one country,” said Podesta. Without the US’ participation, global emission reduction goals will invariably face setbacks. However, Podesta and Zaidi emphasized that while withdrawal from the Paris Agreement would be a setback for the American people, it’s one that can be overcome in time.

Relaxation of Long-Standing Restrictions on Foreign Investment in the Healthcare Sector in China
ARTICLE / CLIENT ALERT
Relaxation of Long-Standing Restrictions on Foreign Investment in the Healthcare Sector in China
November 26, 2024
Read time: 6 min
The demand for medical services in China is growing, with the country’s ageing population set against its potential for economic development. A joint circular released by China’s Ministry of Commerce, National Health Commission and the National Medical Products Administration in September signals a relaxation of China’s long-standing restrictions on foreign investment in the healthcare sector. Given a decline in foreign direct investment (FDI) in China generally, the announcement has garnered significant global attention.
What’s New
The joint circular is a significant relaxation of China’s restrictive policies on foreign investment in the healthcare sector and is aimed at facilitating the registration, launching, and production of related products, which, once registered and approved, can be used nationwide.
The key components of the joint circular were twofold, announcing that China will allow:
- Wholly foreign-owned hospitals to be set up in several major cities, including Beijing and Shanghai; and
- Foreign invested enterprises to engage in biotechnology, in particular, to offer human stem cell and gene therapy services in pilot free-trade zones. These pilot programs are a clear signal of the region’s intention to bring back foreign investment and stabilise growth.
The move from Beijing comes less than two months after the country’s leadership pledged to further open up the market at their key policymaking third plenum, and after Vice-Premier He Lifeng vowed to expand international cooperation and build a new open high-level economic system at the China International Fair for Investment and Trade in the southeastern city of Xiamen, announcing that foreign investment is “an important part of China’s economy and an important force in China’s modernisation drive”.
1. Significance for the establishment of wholly foreign-owned hospitals
Despite China’s 2014 pilots for wholly foreign-owned hospitals, foreign investment has historically been limited to joint ventures regarding established hospitals rather than sole ownership.
As a result of the joint circular, the restriction that foreign investors can only operate medical institutions in joint ventures has been relaxed, and wholly foreign-owned hospitals can now be opened in the cities of Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou and Shenzhen, as well as in the southern island province, Hainan.
- Commentators have noted that the joint document issued by the three departments has a wider scope of opening up than in the past, with the term “wholly foreign-owned” regarded as a breakthrough change which can allow more places to benefit from foreign-funded medical resources.
- Wholly foreign-owned hospitals are now poised to introduce international medical technologies, talent, nursing models, service concepts, and management practices and are an area of interest for foreign investors across the globe.
The joint circular not only assists opening China further for foreign investment, but promotes the in-depth implementation of the Health China strategy. The joint circular presents the opportunity for China to:
- Build a more flexible, incisive and efficient medial service system, with the demand for medical services within China potentially resulting in further prohibitions being lifted beyond the pilot regions in future; and
- Improve the overall medical level, improve the medical environment, and also provide convenience for foreigners seeking medical treatment in China.
The detailed requirements and procedures for wholly foreign-owned hospitals and the foreign investment itself are yet to be released; however, it is already known that foreign investors will not be allowed to acquire public hospitals or run businesses relating to Chinese medicine.
While the joint circular did not provide any information on what the regulations may contain, previous regulations regarding the Shanghai free trade zone pilot indicate that future guidelines may include stipulations on total investment and the level of medical technology required.
Further, due to the involvement of health data and other national information, wholly foreign-owned hospitals may face different regulations in areas such as pre-approval and medical care services. Investors will need to closely monitor the development and implementation of regulations for wholly foreign-owned hospitals, particularly issues related to national treatment, regulatory models, and the free flow of foreign capital.
2. Significance for Biotechnology Development and Application
China’s Negative List has explicitly prohibited “foreign investment in the development and application of human stem cells, gene diagnosis, and treatment technologies” since 2007. With the issuance of the joint circular, foreign investment entities can now engage in these activities within the free trade zones of Beijing, Shanghai, Guangdong, and the Hainan Free Trade Port for the purposes of registration, market authorisation and manufacturing. Once approved, these products may be used nationwide.
The relaxation of restrictions on foreign investment in the development and application of stem cell and gene diagnosis and treatment technologies, must be balanced against ensuring China’s biosecurity, and this has been a long-standing call and effort within the industry. Accordingly, foreign investment entities participating in the pilot program will need to ensure they are aware of and adhere to the relevant Chinese laws and regulations. This includes regulations relating to human genetic resource management, drug clinical trials, drug registration and listing, drug production, and ethical review. Foreign investment entities must also ensure they follow the necessary management procedures.
In addition, foreign investors must be cognisant of the fact that while China’s healthcare market is continuously growing and dynamic, making it one of the most attractive in the world, it is heavily regulated, with high compliance requirements and strong competition. For foreign investors to benefit from the opportunity provided by the joint circular and successfully enter the market, it is crucial they understand and stay abreast of changes in the relevant industry policies and compliance requirements and develop a well-tailored strat

Navigating Regulatory Changes: What to Expect for the CFPB Under the Incoming Trump Administration
ARTICLE / CLIENT ALERT
Navigating Regulatory Changes: What to Expect for the CFPB Under the Incoming Trump Administration
November 26, 2024
Read time: 6 min
As President-elect Donald Trump prepares to assume office in January 2025, businesses should anticipate significant changes in the regulatory landscape, particularly in the oversight and priorities of the Consumer Financial Protection Bureau (“CFPB”). This outlook is informed not only by the policies and practices of Trump’s first term but also by recent statements from the President-elect, congressional Republicans and other stakeholders, which signal a strong intent to pursue deregulation and a shift in the CFPB’s approach to rulemaking and enforcement.
During Trump’s first administration, the CFPB underwent a dramatic transformation. Leadership changes, starting with the appointment of Mick Mulvaney as acting director, brought a marked shift in focus. The CFPB reduced its enforcement actions, prioritized voluntary compliance and streamlined its rulemaking agenda. Mulvaney’s approach, which emphasized minimizing regulatory burdens on businesses, set a tone of deregulatory pragmatism that continued under his successor, Kathy Kraninger.
Despite this shift, the CFPB did not abandon enforcement entirely. It pursued key cases involving redlining and unfair practices, demonstrating that even a deregulatory administration addressed certain high-profile consumer protection issues. Meanwhile, state regulators increased scrutiny of financial institutions and consumer protection practices to fill perceived gaps.
Now, as Trump and congressional Republicans prepare to take full control of the White House, Senate and House, they are reportedly considering sweeping changes to the CFPB’s powers and funding. Potential reforms may include efforts to reduce the CFPB’s authority, curtail its oversight activities and revise its leadership structure. Republican lawmakers have also signaled a desire to shift the CFPB’s funding source from the Federal Reserve to Congress, limiting its independence from congressional budgetary control.
The GOP’s proposed reforms reflect concerns voiced by some industry stakeholders regarding the scope and impact of recent CFPB initiatives, including those targeting overdraft fees and bank switching processes. Conversely, Democrats, including Sen. Elizabeth Warren, argue that any efforts to dismantle or significantly alter the CFPB could face public resistance, as the agency remains recognized for its role in consumer protection.
Looking ahead, President-elect Trump’s team has already signaled plans to continue and expand this deregulatory approach. A leadership overhaul at the CFPB is expected early in the new administration, with current Director Rohit Chopra likely to be replaced. This change will likely result in a recalibration of the CFPB’s priorities, focusing on rolling back or pausing rules initiated under Chopra. Recent public statements suggest potential revisions to rules targeting digital payments, including the newly finalized “larger participant” rule, which subjects major digital payment providers like Apple Pay, Google Pay and Venmo to enhanced federal supervision. This rule is expected to face legal challenges from industry trade groups and could be deprioritized under new CFPB leadership.
The fate of the CFPB’s open banking rule also remains uncertain under the incoming administration. Finalized in October 2024, the rule is intended to promote competition by giving consumers control over their financial data and making that data portable to switch service providers more easily. However, the rule is already facing court challenges from industry groups, including the Bank Policy Institute, which allege that the compliance timelines are onerous and that the CFPB overstepped its authority. A Trump-appointed CFPB director may deprioritize defending the rule, leaving its future uncertain.
Enforcement priorities are also expected to shift. The CFPB under Trump’s leadership may reduce the volume of enforcement actions, favoring a less punitive and more collaborative approach. However, high-visibility issues such as elder fraud, data security and discriminatory practices could still prompt action without significant reductions, especially if public or political pressure arises.
While federal oversight may ease, businesses should remain vigilant about increased state-level regulatory activity. State attorneys general and regulators have historically stepped in to fill perceived gaps during periods of federal pullback, creating a more fragmented compliance landscape. Companies operating across jurisdictions will need to carefully navigate varying state requirements to ensure nationwide compliance.
In addition, consumer advocacy and political dynamics may influence the regulatory agenda, particularly on issues like data privacy and digital payments. Even with a scaled-back CFPB, industry players should anticipate ongoing challenges related to these high-profile issues and ensure they have rigorous policies and procedures in place to address them.
The next four years bring both challenges and opportunities. By staying informed and proactive, businesses can position themselves to thrive in this shifting regulatory environment. Steps businesses should take include:
- Monitoring Regulatory Developments: Stay informed about leadership changes, regulatory rollbacks and state-level initiatives. Understanding the priorities of the new CFPB leadership will be critical.
- Strengthen Compliance Programs: Robust compliance frameworks remain essential to address current obligations and anticipate areas of scrutiny, particularly at the state level.
- Engaging with Legal Counsel: Proactive engagement with regulatory counsel can provide the insights needed to navigate risks, address potential blind spots, and adapt to shifting priorities.
Schulte Roth & Zabel’s lawyers are available to assist you in addressing any questions you may have regarding these developments. Please contact the Schulte Roth & Zabel lawyer with whom you usually work, or any of the following attorneys:
Donald J. Mosher – New York (+1 212.756.2187)
Kara A. Kuchar – New York (+1 212.756.2734)
Betty Santangelo – New York (+1 212.756.2587)
Melissa G.R. Goldstein – Washington, DC (+1 202.729.7471)
Adam J. Barazani – New York (+1 212.756.2519)
Jessica Romano – New York (+1 212.756.2205)
Jesse Weissman – New York (+1 212.756.2460)
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. © 2024 Schulte Roth & Zabel LLP. All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

SEC’s Dealer Rule Vacated
ARTICLE / CLIENT ALERT
SEC’s Dealer Rule Vacated
November 26, 2024
Read time: 7 min
Executive Summary
On Nov. 21, 2024, Judge Reed O’Connor of the US District Court for the Northern District of Texas (“District Court”) vacated recently adopted rules 3a5‑4 and 3a44‑2 (together, the “Dealer Rule”) of the Securities Exchange Act of 1934, as amended (“Exchange Act”).[1] In concluding that the Securities and Exchange Commission (the “SEC” or “Commission”) exceeded its statutory authority in adopting the Dealer Rule, the District Court determined that the Dealer Rule was “untethered from the text, history, and structure of the [Exchange] Act.”[2]
Notably, in determining to vacate the Dealer Rule, the District Court placed significant weight on the fact that “Congress defined the term ‘dealer’ against a pre-existing historical backdrop … indicative of an understanding that dealers have customers.”[3] While it is encouraging that the District Court adopted a view that entities without customers, like private funds, cannot generally be considered “dealers,” it remains to be seen what effect this will have on the SEC’s enforcement efforts, which pre-date the Dealer Rule. Whether the SEC pursues an appeal of the decision vacating the Dealer Rule will be a decision for the new administration.
Background
Exchange Act section 3(a)(5)(A) defines “dealer” as “any person engaged in the business of buying and selling securities … for such person’s own account through a broker or otherwise.” Relatedly, Exchange Act section 3(a)(5)(B) notes that “[t]he term ‘dealer’ does not include a person that buys or sells securities … for such person’s own account, either individually or in a fiduciary capacity, but not as a part of a regular business.” (Emphasis added). The exception provided by Exchange Act section 3(a)(5)(B) is intended to carve-out from the definition of dealer people who trade for their own accounts, but not as part of a regular business (e.g., “traders”).
On Feb. 6, 2024, the Commission adopted the Dealer Rule[4] to “further define” what it means to be “engaged in the business” of buying and selling securities for one’s own account. The Dealer Rule established two non-rebuttable qualitative standards (collectively, the “Qualitative Tests”)[5] that, if met, would require registration with the SEC as a “dealer” or “government securities dealer” (collectively, a “Dealer”).
On March 18, 2024, various associations of private fund managers[6] brought an action challenging the Dealer Rule, alleging, among other things, that the rule violated the Administrative Procedure Act (“APA”) because it exceeded the SEC’s authority under Exchange Act and, separately, was arbitrary and capricious.
District Court Decision
On Nov. 21, 2024, the District Court granted Plaintiffs’ motion for summary judgement, holding that the Commission had exceeded its statutory authority under the Exchange Act in adopting the Dealer Rule, and vacated the Dealer Rule in full. As the District Court found that the Commission had exceeded its statutory authority, the District Court did not address Plaintiffs’ claim that the SEC’s rulemaking was arbitrary and capricious, nor did it rule on the Dealer Rule as applied to private funds in particular.
In granting the Plaintiffs’ motion for summary judgement, the District Court focused heavily on whether being “engaged in the business” of buying and selling securities for one’s own account covers people who do not provide liquidity as a service to customers. The District Court agreed with Plaintiffs’ argument that the “history of the Exchange Act make[s] unmistakably clear that a ‘dealer’ (like a ‘broker’) is in the business of ‘effect[ing] securities transactions for customers.’”[7] Further, the District Court found the Commission’s argument – that the dealer definition covers, and has always been understood to cover, people without customers – would make the dealer-trader distinction “unintelligible.”[8]
While the Commission pointed to two cases from the Eleventh Circuit in support of its position that Dealers do not need customers,[9] the District Court distinguished these cases as being limited to the specific conduct at issue and concluded that neither case supported the proposition that “merely regularly buying and selling securities renders someone [without customers] a dealer.”[10]
Conclusion
While the District Court’s rulings vacated the Dealer Rule in its entirety, market participants should continue to assess whether they might be deemed Dealers under existing SEC guidance. For instance, SEC guidance notes that quoting a market – that is, a simultaneous bid and ask – for a security (for instance, on a disclosed basis in an “over-the-counter” market), holding oneself out as willing to buy and sell a security on a regular basis and engaging in trading in securities for the benefit of others are all indicative of “dealer” status.[11] Firms engaging in such activities should be cognizant of whether their trading counterparties could be viewed as “customers” and whether such arrangements might otherwise be viewed as offering “dealer” services.
Further, the SEC has successfully brought cases in recent years finding certain participants in the convertible debt market[12] to be unregistered dealers. Such cases and related enforcement actions have been based on the statutory definition of “dealer” under the Exchange Act rather than the Dealer Rule. Notwithstanding the absence of clear customer relationships, the District Court discussed two of these cases and indicated that the holdings in those two cases are compatible with the District Court’s holdings in the Dealer Litigations.[13] While SEC staff may, under the incoming administration, continue to bring enforcement actions for this type of convertible debt financing activity, we would not expect the SEC to materially expand the type of activity targeted in such actions.
Authored by William Barbera, Julian Rainero, Derek Lacarrubba and Kris Kendall.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
[1] Nat’l Ass’n of Priv. Fund Managers v. SEC, No. 4:24-cv-00250 (N.D. Tex. Nov. 21, 2024) (“Private Fund Litigation”); Crypto Freedom All. of Tex. v. SEC, No. 4:24-cv-00361 (N.D. Tex. Nov. 21, 2024) (the “Crypto Security Litigation,” together with Private Fund Litigation the “Dealer Litigations”).
[2] Nat’l Ass’n of Priv. Fund Managers, No. 4:24-cv-00250, at 7.
[3] Id. at 9.
[4] “Further Definition of ‘As a Part of a Regular Business’ in the Definition of Dealer and Government Securities Dealer,” Exchange Act Release No. 34-99477 (February 6, 2024) 89 Fed. Reg. 14938 (Feb. 29, 2024). See also SRZ’s previous Alert regarding the substance of the Dealer Rules, available here.
[5] One test that targeted the regularity of a market participant’s expressions of trading interest and another that targets a market participant’s primary source of revenue.
[6] The National Association of Private Fund Managers; Alternative Investment Management Association, Limited; and Managed Funds Association were plaintiffs in the Private Fund Litigation. The parallel Crypto Security Litigation was brought by the Crypto Freedom Alliance of Texas, et al. The Private Fund Litigation and Crypto Security Litigation plaintiffs are collectively referred to herein as the “Plaintiffs.”
[7] Nat’l Ass’n of Priv. Fund Managers, No. 4:24-cv-00250, at 10 (quoting Pls.’ Br. in Supp. Mot. Summ. J. 10, ECF No.). (Emphasis added).
[8] Id. at 9.
[9] See SEC v. Almagarby, 92 F.4th 1306 (11th Cir. 2024); SEC v. Keener, 102 F.4th 1328 (11th Cir. 2024).
[10] Nat’l Ass’n of Priv. Fund Managers, No. 4:24-cv-00250, at 15.
[11] See Exchange Act Release No. 34-40594, 63 Fed. Reg. 59362 (Nov. 3, 1998).
[12] Generally, purchasers of convertible debt notes from microcap issuers who subsequently convert such notes into common stock at a steep discount to the stock’s then-current market price and quickly liquidate the stock following receipt.
[13] See FN 9, supra.
